|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenues | |||||
| Gross profit (loss) | |||||
| Operating expenses: | |||||
| Allowance for credit losses | |||||
| Selling expenses | |||||
| General and administrative expenses | |||||
| Research and development expenses | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Other income (expenses): | |||||
| Interest expense | |||||
| Amortization of debt issuance costs | |||||
| Government subsidy income | |||||
| Interest income | |||||
| Gain (loss) on disposal of subsidiaries | |||||
| Share of net loss from equity investee | |||||
| Other income (expenses) | |||||
| Total other (expenses) income, net | |||||
| Loss before income taxes | |||||
| Income tax (expenses) benefits | |||||
| Net loss | |||||
| Net loss | |||||
| Deemed dividend on conversion of Convertible Preferred Shares to Ordinary Shares | |||||
| Net income (loss) attributable to Shareholders | |||||
| Other comprehensive income (loss) : | |||||
| Foreign currency translation (loss) gain | |||||
| Comprehensive (loss) income | |||||
| Comprehensive loss. | |||||
| Loss per share. | |||||
| Basic | |||||
| Diluted | |||||
| Basic | |||||
| Diluted | |||||
Loading...